These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20419850)

  • 1. Choroidal neovascular membrane in persistent fetal vasculature syndrome managed with intravitreal pegaptanib sodium in an infant.
    Vinekar A; Sund N; Quiram P; Capone A
    Retina; 2010 Apr; 30(4 Suppl):S41-4. PubMed ID: 20419850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of naïve lesions in neovascular age-related macular degeneration with pegaptanib.
    Quiram PA; Hassan TS; Williams GA
    Retina; 2007 Sep; 27(7):851-6. PubMed ID: 17891008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of choroidal neovascularization following injection of pegaptanib sodium (macugen) in two eyes with neovascular age-related macular degeneration.
    Williams AJ; Fekrat S
    Am J Ophthalmol; 2006 Oct; 142(4):683-4. PubMed ID: 17011868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
    Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR
    Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography findings during pegaptanib therapy for neovascular age-related macular degeneration.
    Emerson GG; Flaxel CJ; Lauer AK; Stout JT; Emerson MV; Nolte S; Wilson DJ; Klein ML
    Retina; 2007; 27(6):724-9. PubMed ID: 17621181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Co-existent occult choroidal neovascular membrane and macular hole.
    Singh RP; Kaiser PK
    Surv Ophthalmol; 2007; 52(5):547-50. PubMed ID: 17719376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RPE tears after pegaptanib treatment in age-related macular degeneration.
    Chang LK; Flaxel CJ; Lauer AK; Sarraf D
    Retina; 2007 Sep; 27(7):857-63. PubMed ID: 17891009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranibizumab-pegaptanib therapy for idiopathic choroidal neovascularization: report of a case.
    Friberg TR
    Semin Ophthalmol; 2007; 22(3):137-9. PubMed ID: 17763232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of CNV in angioid streaks by intravitreal use of specific anti-VEGF165 Aptamer (pegaptanib sodium): long-term results.
    Cekiç O; Göçmez E; Kocabora MS
    Curr Eye Res; 2011 May; 36(5):492-5. PubMed ID: 21501082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials.
    ; D'Amico DJ; Masonson HN; Patel M; Adamis AP; Cunningham ET; Guyer DR; Katz B
    Ophthalmology; 2006 Jun; 113(6):992-1001.e6. PubMed ID: 16647134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal pegaptanib sodium (Macugen) for treatment of myopic choroidal neovascularization: a morphologic and functional study.
    Rinaldi M; Chiosi F; DellʼOmo R; Romano MR; Parmeggiani F; Semeraro F; Menzione M; Costagliola C
    Retina; 2013 Feb; 33(2):397-402. PubMed ID: 22990315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: a retrospective consecutive case series.
    Kohly RP; Muni RH; Kertes PJ; Lam WC
    Can J Ophthalmol; 2011 Feb; 46(1):46-50. PubMed ID: 21283157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience in the treatment of neovascular age-related macular degeneration with pegaptanib].
    Maier M; Feucht N; Huebner M; Lohmann C
    Klin Monbl Augenheilkd; 2008 Jun; 225(6):582-7. PubMed ID: 18516780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration.
    Ricci F; Missiroli F; Cedrone C; Grossi M; Regine F
    Semin Ophthalmol; 2010; 25(1-2):16-20. PubMed ID: 20507192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization.
    Liggett PE; Colina J; Chaudhry NA; Tom D; Haffner G
    Am J Ophthalmol; 2006 Dec; 142(6):1072-4. PubMed ID: 17157599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
    ; Chakravarthy U; Adamis AP; Cunningham ET; Goldbaum M; Guyer DR; Katz B; Patel M
    Ophthalmology; 2006 Sep; 113(9):1508.e1-25. PubMed ID: 16828500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
    Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegaptanib: choroidal neovascularization in patients with age-related macular degeneration and previous arterial thromboembolic events.
    Battaglia Parodi M; Di Bartolo E; Brue C; Cappello E; Furino C; Giuffrida S; Imparato M; Reibaldi M
    Eur J Ophthalmol; 2018 Jan; 28(1):58-62. PubMed ID: 29077191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous vascular endothelial growth factor after intravitreal injection of pegaptanib or ranibizumab in patients with age-related macular degeneration.
    Sawada O; Miyake T; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Retina; 2010; 30(7):1034-8. PubMed ID: 20616682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.